[Ended]Indonesian Neurology NMO Case Teleconference

Ver 1.6

Local Time At Main Venue

2017/03/29 (Wed) 13:00-120min, Jakarta Pusat,ID (UTC+07:00)

Organizer

Riwanti Estiasari

Contents

Neurology

Topics

1. Progressive cognitive impairment with AQP4 antibody positive 2. NMOSD with anti MOG positive

A-35-year-old female came to hospital due to communication and swallowing difficulty. She only said 1-2 words without any expression on her face. She also not able to walk and her both leg were spastic. Her symptoms was started with memory impairment since 3 years ago. The memory problem progress was quite fast enough until she cannot work as high school teacher in 1 year. Her ability in doing daily activity also decreased and all her extremities become spastic. Six years ago she has experienced of auditory hallucination and went to psychiatrist. She got haloperidol for couple weeks and the hallucination disappeared. No history of head trauma, fever or other disease. Physical examination revealed GCS E4M6 V(cognitive impairment), no hemiparesis, physiological reflex increased with Achilles clonus positive. Brain MRI with contrast showed bilateral periventricular hyperintens lesion in T2 with brain atrophy. Cervical MRI within normal limit. Laboratory result, AQP4 antibody serum positiv

Connection Method

H.323 , Vidyo

Style

Conference

Server At

Kyushu University

Chairs

Chair

Riwanti Estiasari
University of Indonesia / ID

Co-Chair1

Junichi Kira
Kyushu University Hospital / JP

Co-Chair2

Pukovisa Prawiroharjo
University of Indonesia / ID

Chief Engineer1

Nopa Krismanto
University of Indonesia / ID

Participating Institutions

Note: The institution shown in red is not confirmed.

City, Country

Institution

Moderator

Schedule

Precautions

• The conference will be recorded by the photos and movies.

• Pictures taken at the conference may be published in TEMDEC home page, annual report and conference presentations.

• Do not present the personal information of patients any in oral and presentation materials without obtaining the patient’s consent.

* For more information, please refer to the TEMDEC policy.